Stuart A. Tross
Net Worth
Last updated:
What is Stuart A. Tross net worth?
The estimated net worth of Dr. Stuart A. Tross is at least $10,003,366 as of 6 Nov 2024. He owns shares worth $3,830,076 as insider, has earned $1,066,250 from insider trading and has received compensation worth at least $5,107,040 in MannKind Corporation.
What is the salary of Stuart A. Tross?
Dr. Stuart A. Tross salary is $638,380 per year as Chief People & Workplace Officer in MannKind Corporation.
How old is Stuart A. Tross?
Dr. Stuart A. Tross is 58 years old, born in 1967.
What stocks does Stuart A. Tross currently own?
As insider, Dr. Stuart A. Tross owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
MannKind Corporation (MNKD) | Chief People & Workplace Officer | 967,191 | $3.96 | $3,830,076 |
What does MannKind Corporation do?
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocrinologists, and other healthcare providers for the treatment of hypothyroidism. The company has a license and collaboration agreement with United Therapeutics Corporation. It also has an agreement with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), a synthetic form of human vasoactive intestinal peptide to help protect cells against inflammatory conditions. MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California.
Stuart A. Tross insider trading
MannKind Corporation
Dr. Stuart A. Tross has made 4 insider trades between 2017-2024, according to the Form 4 filled with the SEC. Most recently he sold 55,000 units of MNKD stock worth $403,700 on 6 Nov 2024.
The largest trade he's ever made was exercising 55,000 units of MNKD stock on 6 Nov 2024. As of 6 Nov 2024 he still owns at least 967,191 units of MNKD stock.
MannKind key executives
MannKind Corporation executives and other stock owners filed with the SEC:
- Dr. David B. Thomson (58) Executive Vice President, Gen. Counsel & Sec.
- Dr. Michael E. Castagna (48) Chief Executive Officer & Director
- Dr. Stuart A. Tross (58) Chief People & Workplace Officer
- Mr. Joseph Kocinsky M.B.A., M.S. (61) Chief Technology Officer
- Mr. Steven B. Binder (62) Chief Financial Officer